Biomedical Company Announces Advancements For Potential Adjustment Disorder Treatment
Psyence Biomed Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial.
Disclaimer: This article is intended for informational purposes only. It does not constitute medical advice, recommendation, or endorsement of any treatment or company. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Real-time information is…